Live Breaking News & Updates on Division Of Rheumatology At

Stay updated with breaking news from Division of rheumatology at. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

An analysis of the ORAL Surveillance trial details the efficacy of tofacitinib relative to TNF inhibition based on history of ASCVD and baseline cardiovascular risk. ....

United States , George Karpouzas , Deepak Bhatt , David Geffen School Of Medicine , American College Of Rheumatology , European Congress , Division Of Rheumatology At , Lundquist Institute George Karpouzas , Lundquist Institute , Blackbox Warning , David Geffen School , New England Journal , American College , Cancer Risk ,

Use of Biologics Could Lower Cardiovascular Risk in Rheumatoid Arthritis

George Karpouzas, MD, discusses the results of a study he presented at EULAR 2023 examining associations between bDMARD use and cardiovascular risk later in life. ....

George Karpouzas , Lundquist Institute George Karpouzas , Division Of Rheumatology At , European Congress , David Geffen School Of Medicine , Lundquist Institute , David Geffen School ,

Long COVID and Patients with Rheumatic Disease: Perspective from EULAR 2023

A group of rheumatologists attending EULAR 2023 provide perspective on their concern regarding the potential threat posed by long COVID in patients with rheumatic disease. ....

George Karpouzas , Brian Lamoreaux , Lars Erik Kristensen , R George Karpouzas , Cozianna Ciurtin , Coziana Ciurtin , University College London , Global Rheumatology Alliance Vaccine , Parker Institute , Division Of Rheumatology At , United Nations , David Geffen School Of Medicine , Lunquist Institute , European Congress , World Health Organization , Rheumatology Alliance Vaccine Survey , David Geffen School , Horizon Therapeutics , Rheumatology Alliance Vaccine ,